Moshirfar Majid, Albarracin Julio C, Desautels Jordan D, Birdsong Orry C, Linn Steven H, Hoopes Phillip C
HDR Research Center, Hoopes Vision, Draper.
John A Moran Eye Center, Department of Ophthalmology and Visual Sciences, University of Utah School of Medicine, Salt Lake City, UT.
Clin Ophthalmol. 2017 Sep 15;11:1683-1688. doi: 10.2147/OPTH.S147011. eCollection 2017.
Four cases of corneal ectasia after small-incision lenticule extraction (SMILE) have been reported. In this review, we provide an overview of the published literature on corneal ectasia after SMILE and risk factors associated with this complication.
Case reports were identified by a search of seven electronic databases for pertinent heading terms between 2011 and July 2017. We identified patient characteristics and surgical details including preoperative topography, central corneal thickness, and anterior keratometry (Km). Residual stromal bed (RSB) values not reported were computed using VisuMax ReLEx SMILE software Version 2.10.10. Preoperative ectasia risk was measured using the Randleman Ectasia Risk Score System (ERSS). Percent tissue alteration was calculated for each patient as described by Santhiago et al.
Seven eyes of four patients developed corneal ectasia post SMILE. Two patients had abnormal topography in both eyes. One patient had abnormal topography in one eye. Only one patient was noted to have normal topography in both eyes and later developed ectasia in one eye in the absence of any known risk factors. The mean Randleman ectasia risk score was 4±3 (range: 1-8). The mean calculated percent tissue altered (PTA) was 38%±6% (range: 30%-47%).
A majority of reported ectasia cases occurred in patients with subclinical keratoconus. These conditions may be exacerbated by SMILE and should be considered absolute contraindications to the procedure. Three patients were identified to have high risk based on the ERSS, and one patient exhibited a PTA ≥40%. We formulated a modification to the current calculation of PTA that takes into account the differences in tissue altered between SMILE and laser in situ keratomileusis (LASIK). More studies are needed to fully quantify the risk of ectasia. For now, we propose adopting the same exclusion criteria used for LASIK in the SMILE procedure until more specific metrics have been validated.
已报道了4例小切口透镜切除术(SMILE)后发生角膜扩张的病例。在本综述中,我们概述了已发表的关于SMILE术后角膜扩张及与此并发症相关的危险因素的文献。
通过检索7个电子数据库,查找2011年至2017年7月期间的相关标题词来确定病例报告。我们确定了患者特征和手术细节,包括术前地形图、中央角膜厚度和前角膜曲率(Km)。未报告的剩余基质床(RSB)值使用VisuMax ReLEx SMILE软件2.10.10版进行计算。术前扩张风险使用兰德尔曼扩张风险评分系统(ERSS)进行测量。按照圣地亚哥等人的描述计算每位患者的组织改变百分比。
4例患者的7只眼在SMILE术后发生了角膜扩张。2例患者双眼地形图异常。1例患者单眼地形图异常。仅1例患者双眼地形图正常,且在无任何已知危险因素的情况下,后来单眼发生了扩张。兰德尔曼扩张风险评分的平均值为4±3(范围:1 - 8)。计算得出的平均组织改变百分比(PTA)为38%±6%(范围:30% - 47%)。
大多数报道的扩张病例发生在亚临床圆锥角膜患者中。这些情况可能因SMILE而加重,应被视为该手术的绝对禁忌证。根据ERSS确定3例患者具有高风险,1例患者的PTA≥40%。我们对当前PTA的计算方法进行了修改,以考虑SMILE与准分子原位角膜磨镶术(LASIK)之间组织改变的差异。需要更多研究来全面量化扩张风险。目前,我们建议在SMILE手术中采用与LASIK相同的排除标准,直到更具体的指标得到验证。